| 1 | POS0477 RELATIONSHIP BETWEEN SHARED EPITOPE STATUS AND REFRACTORY RHEUMATOID ARTHRITIS | Annals of the Rheumatic Diseases | Kristin Wipfler, E. Alemao et al. | 1 |
| 2 | Cycling of tumor necrosis factor inhibitors versus switching to different mechanism of action therapy in rheumatoid arthritis patients with inadequate response to tumor necrosis factor inhibitors: a Bayesian network meta-analysis | Therapeutic Advances in Musculoskeletal Disease | Alberto Migliore, E. Alemao et al. | 22 |
| 3 | PIN33 How Does Mortality Differ In Early Vs. Late Diagnosed Nontuberculous Mycobacterial Lung Disease Among Patients With Chronic Obstructive Pulmonary Disease (COPD) | Value in Health | Theodore K. Marras, E. Alemao et al. | 3 |
| 4 | Evaluation of the Effect of Diabetes on Rheumatoid Arthritis–related Outcomes in an Electronic Health Record–based Rheumatology Registry | The Journal of Rheumatology | Huifeng Yun, Fenglong Xie et al. | 7 |
| 5 | Immunosuppression and the risk of readmission and mortality in patients with rheumatoid arthritis undergoing hip fracture, abdominopelvic and cardiac surgery | Annals of the Rheumatic Diseases | Michael George, Joshua F. Baker et al. | 12 |
| 6 | Trajectories of health-related quality of life among renal transplant patients associated with graft failure and symptom distress: Analysis of the BENEFIT and BENEFIT-EXT trials | American Journal of Transplantation | Jennifer L. Beaumont, Martin S. Polinsky et al. | 15 |
| 7 | Supplementing Claims Data with Electronic Medical Records to Improve Estimation and Classification of Rheumatoid Arthritis Disease Activity: A Machine Learning Approach | ACR Open Rheumatology | Candace H. Feldman, Kazuki Yoshida et al. | 10 |
| 8 | Efficacy of Abatacept and Adalimumab in Patients with Early Rheumatoid Arthritis With Multiple Poor Prognostic Factors: Post Hoc Analysis of a Randomized Controlled Clinical Trial (AMPLE) | Rheumatology and Therapy | Roy Fleischmann, Michael E. Weinblatt et al. | 11 |
| 9 | Do Poor Prognostic Factors in Rheumatoid Arthritis Affect Treatment Choices and Outcomes? Analysis of a US Rheumatoid Arthritis Registry | The Journal of Rheumatology | E. Alemao, Heather J. Litman et al. | 2 |
| 10 | Conceptual model for the health technology assessment of current and novel interventions in rheumatoid arthritis | PLoS ONE | E. Alemao, Maiwenn Al et al. | 9 |
| 11 | A window of opportunity for abatacept in RA: is disease duration an independent predictor of low disease activity/remission in clinical practice? | Clinical Rheumatology | Leslie R. Harrold, Heather J. Litman et al. | 13 |
| 12 | Effect of Anticitrullinated Protein Antibody Status on Response to Abatacept or Antitumor Necrosis Factor-α Therapy in Patients with Rheumatoid Arthritis: A US National Observational Study | The Journal of Rheumatology | Leslie R. Harrold, Heather J. Litman et al. | 39 |
| 13 | Association of anti-cyclic citrullinated protein antibodies, erosions, and rheumatoid factor with disease activity and work productivity: A patient registry study | Seminars in Arthritis and Rheumatism | E. Alemao, Zhenchao Guo et al. | 16 |
| 14 | Patient-Reported Outcomes Following 12 Months of Therapy with Abatacept (Plus Methotrexate or as Monotherapy) or Methotrexate and up to 6 Months after Treatment Withdrawal in Patients with Early Rheumatoid Arthritis | Data Archiving and Networked Services (DANS) | D E Furst, Gerd R Burmester et al. | 2 |
| 15 | Development of a diabetes treatment simulation model: with application to assessing alternative treatment intensification strategies on survival and diabetes‐related complications | Diabetes Obesity and Metabolism | E. Alemao, D. Yin et al. | 28 |
| 16 | Cost Effectiveness of Adding Ezetimibe to Atorvastatin Therapy in Patients Not at Cholesterol Treatment Goal in Canada | PharmacoEconomics | Michele Kohli, Cheryl Attard et al. | 18 |
| 17 | Evaluation of Lipid-Lowering Therapy and Cholesterol Goal Attainment in Finland | American Journal of Cardiovascular Drugs | E. Alemao, Harri Sintonen et al. | 15 |
| 18 | Statins are less effective in common daily practice among patients with hypercholesterolemia: the REALITY-PHARMO study; | Current Medical Research and Opinion | Wim Goettsch, Donald Yin et al. | 27 |
| 19 | National economic impact of tirofiban for unstable angina and myocardial infarction without ST elevation; example from the United Kingdom | International Journal of Cardiology | Ameet Bakhai, Marcus Flather et al. | 7 |
| 20 | A meta-analysis of the dose-response relationship of inhaled corticosteroids in adolescents and adults with mild to moderate persistent asthma | Clinical Therapeutics | Jean Bousquet, Rami Ben‐Joseph et al. | 47 |